Bindarit - ≥98%, high purity , CAS No.130641-38-2, Inhibitor of fatty acid binding protein 4

Item Number
B129927
Grouped product items
SKUSizeAvailabilityPrice Qty
B129927-5mg
5mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$142.90
B129927-10mg
10mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$236.90
B129927-50mg
50mg
In stock
$593.90

CCL2, CCL7 and CCL8 inhibitor. Anti-inflammatory agent.

Basic Description

Synonyms2-[1(1-benzyl-1H-indazol-3-yl)methoxy]-2-methylpropanoic acid | AS-72769 | D03116 | SB16551 | 4-Hydroxymethylbutazolidine hemisuccinate | AB01566103_02 | Q27281631 | AF2838 | AF-2838 | HY-B0498 | BCP22728 | SW219174-1 | AF 2838 | Bindarit (USAN/INN) | HMS
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsBindarit(AF-2838), a CCL2, CCL7 and CCL8 inhibitor, is an anti-inflammatory agent.CCL2, CCL7 and CCL8 inhibitor. Anti-inflammatory agent. Shows antiproliferative, antimetastatic and antitumor effects in vivo. Prevents neuroinflammation in vivo . Orally ac
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of fatty acid binding protein 4
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

Bindarit exhibits selective inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.

Associated Targets(Human)

FABP4 Tchem Fatty acid-binding protein, adipocyte (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SLC16A3 Tchem Monocarboxylate transporter 4 (196 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name 2-[(1-benzylindazol-3-yl)methoxy]-2-methylpropanoic acid
INCHI InChI=1S/C19H20N2O3/c1-19(2,18(22)23)24-13-16-15-10-6-7-11-17(15)21(20-16)12-14-8-4-3-5-9-14/h3-11H,12-13H2,1-2H3,(H,22,23)
InChi Key MTHORRSSURHQPZ-UHFFFAOYSA-N
Canonical SMILES CC(C)(C(=O)O)OCC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3
Isomeric SMILES CC(C)(C(=O)O)OCC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3
PubChem CID 71354
Molecular Weight 324.37

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

4 results found

Lot NumberCertificate TypeDateItem
B2211287Certificate of AnalysisNov 17, 2023 B129927
B2211291Certificate of AnalysisNov 17, 2023 B129927
I1516056Certificate of AnalysisMar 16, 2023 B129927
B2211308Certificate of AnalysisFeb 16, 2022 B129927

Chemical and Physical Properties

SolubilityDMSO 65 mg/mL Water <1 mg/mL Ethanol 65 mg/mL

Related Documents

Citations of This Product

1. Chan-juan Chai, Yao Sun, Rui-fang Chi, Hui-yu Yang, Bin Yang, Bao Li.  (2024)  Astragaloside IV alleviates LPS-induced cardiomyocyte hypertrophy and collagen expression associated with CCL2-mediated activation of NF-κB signaling pathway.  BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,  693  (149367).  [PMID:38091841] [10.1016/j.bbrc.2023.149367]

References

1. Shen Z, Kuang S, Zhang M, Huang X, Chen J, Guan M, Qin W, Xu HHK, Lin Z.  (2020)  Inhibition of CCL2 by bindarit alleviates diabetes-associated periodontitis by suppressing inflammatory monocyte infiltration and altering macrophage properties..  Cell Mol Immunol,  71  (13): (1755-70).  [PMID:32678310] [10.1021/op500134e]
2. Oddi S, Scipioni L, Totaro A, Angelucci C, Dufrusine B, Sabatucci A, Tortolani D, Coletta I, Alisi MA, Polenzani L et al..  (2019)  The anti-inflammatory agent bindarit acts as a modulator of fatty acid-binding protein 4 in human monocytic cells..  Sci Rep,  (1): (15155).  [PMID:31641194] [10.1021/op500134e]
3. Shen T et al..  (2015)  15-Lipoxygenase and 15-hydroxyeicosatetraenoic acid regulate intravascular thrombosis in pulmonary hypertension..  Am J Physiol Lung Cell Mol Physiol,  309  (5): (L449-62).  [PMID:26092993]
4. Kripnerová M et al..  (2021)  Complex Interplay of Genes Underlies Invasiveness in Fibrosarcoma Progression Model..  J Clin Med,  10  (11):   [PMID:34070472]
5. Chan-juan Chai, Yao Sun, Rui-fang Chi, Hui-yu Yang, Bin Yang, Bao Li.  (2024)  Astragaloside IV alleviates LPS-induced cardiomyocyte hypertrophy and collagen expression associated with CCL2-mediated activation of NF-κB signaling pathway.  BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,  693  (149367).  [PMID:38091841] [10.1016/j.bbrc.2023.149367]

Solution Calculators